Cannabis drug thumbs-up
Canada has become the first country in the world to approve a cannabis-derived drug. On Tuesday, UK-based GW Pharmaceuticals announced that its product, Sativex, has been given the go-ahead by Health Canada for pain relief in adults with multiple sclerosis (see New Scientist, 5 February, p 38).
Emergency biotech ban
European Union officials voted on 15 April to slap emergency restrictions on US exports of animal feed suspected of containing Bt10, an unauthorised transgenic maize. No corn gluten or “brewers grain” can now be imported unless accompanied by accredited laboratory tests demonstrating it is free of…
